Publicação
Anti-obesity potential of a yogurt functionalized with a CLNA-rich pomegranate oil
| dc.contributor.author | Machado, Manuela | |
| dc.contributor.author | Sousa, Sérgio | |
| dc.contributor.author | Rodriguez-Alcalá, Luís M. | |
| dc.contributor.author | Gomes, Ana Maria | |
| dc.contributor.author | Pintado, Manuela | |
| dc.date.accessioned | 2023-09-11T18:49:16Z | |
| dc.date.available | 2023-09-11T18:49:16Z | |
| dc.date.issued | 2023-11 | |
| dc.description.abstract | Pomegranate oil is rich in conjugated linolenic acids, compounds which have attracted attention due to their potential applicability in obesity management as they are capable of modulating leptin and adiponectin secretion and regulate fatty acids storage and glucose metabolism. Among the possible bioactive foodstuffs capable of delivering these bioactive compounds yogurts have shown potential. Thus, the purpose of this work was to develop functional yogurts through the addition of pomegranate oil either in its free or encapsulated (used as a protective strategy against oxidation and gastrointestinal tract passage) forms. To that end, the pomegranate oil (free and encapsulated) was incorporated in yogurt and the functional yogurt capacity to modulate hepatic lipid accumulation, adipocyte metabolism (in terms of lipolysis, and adipokines secretion) and immune response was evaluated. The results obtained showed that the pomegranate oil's incorporation led to an improvement in the yogurts' nutritional values, with a reduction in its atherogenic and thrombogenic indexes (more than 78% for atherogenic and 76% for thrombogenic index) and an enhancement of its hypocholesterolemic/hypercholesterolemic ratio (more than 62%) when compared to the control yogurt. Furthermore, data also showed for the first time how these functional yogurts promoted modulation of metabolic processes post GIT as they were capable of reducing by 40% triglycerides accumulation in steatosis-induced Hep G2 cells and by 30 % in differentiated adipocytes. Moreover, samples also showed a capacity to modulate the leptin and adiponectin secretion (56 % of increase in adiponectin) and reduce the IL-6 secretion (ca 44%) and TNF-α (ca 12%) in LPS-stimulated cells. Thus, the CLNA-rich yogurt here developed showed potential as a viable nutraceutical alternative for obesity management. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.doi | 10.1016/j.foodres.2023.113364 | pt_PT |
| dc.identifier.eid | 85168545906 | |
| dc.identifier.issn | 0963-9969 | |
| dc.identifier.uri | http://hdl.handle.net/10400.14/42258 | |
| dc.identifier.wos | 001064960200001 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Conjugated linolenic acids | pt_PT |
| dc.subject | Dairy products | pt_PT |
| dc.subject | Immune response | pt_PT |
| dc.subject | Lipid metabolism | pt_PT |
| dc.title | Anti-obesity potential of a yogurt functionalized with a CLNA-rich pomegranate oil | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.title | Food research international | pt_PT |
| oaire.citation.volume | 173 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |